Only open-market buys / sells (codes P/S) are a conviction signal; grants, option exercises, tax-withholding, and gifts are compensation mechanics, shown but greyed. The trailing 12-month tallies run to today but the store covers filings through 2026-06-30 only (SEC bulk data sets publish quarterly), so recent activity may be absent.
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | Mor George Adi | Director,Officer | −Other | 18,750 | — | — |
| 2026-05-29 | Mor George Adi | Director,Officer | −Other | 31,712 | — | — |
| 2026-05-29 | Mor George Adi | Director,Officer | −Buy | 4,926 | $2.08 | $10,246 |
| 2026-05-29 | Mor George Adi | Director,Officer | −Buy | 4,878 | $2.05 | $10,000 |
| 2023-01-03 | Mor George Adi | Director,Officer | −Sell | 7,700 | $5.03 | $38,731 |
| 2023-01-03 | Mor George Adi | Director,Officer | −Sell | 6,100 | $5.03 | $30,683 |
| 2023-01-03 | OrbiMed Israel BioFund GP Limited Partnership | TenPercentOwner | −Sell | 266,376 | $3.34 | $889,696 |
| 2023-01-03 | OrbiMed Israel BioFund GP Limited Partnership | TenPercentOwner | −Sell | 70,524 | $4.51 | $318,063 |
| 2022-11-16 | Mor George Adi | Director,Officer | −Sell | 257,248 | $2.08 | $535,076 |
| 2022-11-16 | Mor George Adi | Director,Officer | −Sell | 324,775 | $2.08 | $675,532 |
| 2022-11-16 | Cohen Neil Harris | Director | −Sell | 2,409 | $2.00 | $4,818 |
| 2022-05-24 | Maryles Joel Michael | Director | +Buy | 33 | $2.76 | $91 |
| 2022-05-24 | Maryles Joel Michael | Director | +Buy | 400 | $2.89 | $1,156 |
| 2022-05-18 | Cohen Neil Harris | Director | +Buy | 2,000 | $3.19 | $6,380 |
| 2022-03-18 | Maryles Joel Michael | Director | +Buy | 500 | $4.32 | $2,160 |
| 2022-03-18 | Maryles Joel Michael | Director | +Buy | 500 | $4.36 | $2,180 |
| 2022-03-16 | Marvin Donald | Officer | +Buy | 250 | $3.25 | $813 |
| 2022-03-16 | Marvin Donald | Officer | +Buy | 250 | $3.30 | $825 |
| 2022-03-14 | Cohen Neil Harris | Director | +Buy | 2,000 | $4.20 | $8,400 |
| 2022-03-14 | Cohen Neil Harris | Director | +Buy | 2,000 | $4.30 | $8,600 |
| 2022-03-14 | Cohen Neil Harris | Director | +Buy | 2,000 | $4.56 | $9,120 |
| 2022-03-14 | Pfost Dale R | Director,Officer | +Buy | 1,800 | $3.98 | $7,164 |
| 2022-03-14 | Pfost Dale R | Director,Officer | +Buy | 700 | $3.97 | $2,779 |
| 2022-03-14 | Marvin Donald | Officer | +Buy | 250 | $3.98 | $995 |
| 2022-03-14 | Marvin Donald | Officer | +Buy | 250 | $4.00 | $1,000 |
| 2022-03-14 | Marvin Donald | Officer | +Buy | 250 | $4.20 | $1,050 |
| 2022-03-14 | Marvin Donald | Officer | +Buy | 250 | $4.10 | $1,025 |
| 2022-03-14 | Marvin Donald | Officer | +Buy | 250 | $3.90 | $975 |
| 2022-03-11 | Darvish Nissim | Director | +Buy | 1,200 | $4.28 | $5,136 |
| 2021-12-06 | Cohen Neil Harris | Director | +Buy | 2,000 | $7.43 | $14,860 |
| 2021-03-16 | THIEL PETER | TenPercentOwner | +Buy | 230,536 | — | — |
| 2021-03-16 | OrbiMed Israel GP Ltd. | TenPercentOwner | +Grant | 288,170 | $17.35 | $5M |
| 2021-03-16 | Cohen Neil Harris | Director | +Buy | 2,409 | $41.51 | $99,998 |
Source: the SEC bulk insider (Form 3/4/5) data sets — non-derivative transactions in the issuer's common stock, most recent first, covering filings through 2026-06-30. Insiders file within 2 business days of a transaction, but the bulk sets publish quarterly, so this store lags live filings; option/derivative lines are excluded. Codes: P buy · S sell · A grant · M/X/C exercise · F tax · G gift.
Model-derived estimate for research. See the Disclaimer.
